Transformative Impact of OBBBA on R&D Tax Strategies

The realm of innovation and development within various industries hinges significantly on Research and Experimental (R&E) expenditures. Traditionally, these expenditures have played a pivotal role in spurring innovation through tax incentives, allowing businesses to deduct such costs and thereby lessen their taxable income.

The One Big Beautiful Bill Act (OBBBA), enacted on July 4, 2025, restores an essential tax incentive by reinstating the immediate deduction of domestic R&E expenditures. This move reverses a challenging amendment introduced by the Tax Cuts and Jobs Act (TCJA) of 2017, under new Internal Revenue Code (IRC) Section 174A, though it enforces stricter rules for foreign R&E activities. Image 3

Defining R&E Expenses - Commonly referred to as R&D costs, these expenses encompass costs associated with the development or enhancement of products, including software. Key cost components include:

  • Salaries for personnel engaged in research-related tasks.

  • Materials and supplies consumed during research activities.

  • Fees for third-party research services.

  • Overhead costs linked to R&E, such as facilities and equipment expenses like rent, utilities, insurance, and repairs.

These costs are broadly defined by the IRS to foster diverse innovative undertakings.

Historical Context of R&E Expensing - Prior to the TCJA's effective date of December 31, 2021, businesses could either immediately deduct R&E costs or opt to capitalize and amortize them over a minimum of 60 months, benefiting companies heavily focused on innovation.

The TCJA, starting in 2022, altered this by imposing mandatory capitalization and amortization, resulting in substantial tax implications for companies, especially startups with prolific R&D activities but limited revenue streams, as they faced delays in realizing tax benefits.

The OBBBA's Impact on Domestic R&E - Effective from tax years post-December 31, 2024, Section 174A significantly shifts the paradigm for domestic R&E. Businesses can now permanently and immediately deduct 100% of domestic R&E expenditures in the incurred year, revitalizing pre-2022 favorable conditions and encouraging U.S.-based research efforts. Conversely, the mandate for foreign R&E expenditures means maintaining a 15-year amortization plan, pushing multinational entities to rethink their R&D location strategies for optimal tax benefits.Image 2

Let’s Start a Conversation.
You can count on us for professional guidance along with timely, and reliable tax services. If you’re ready to get started, or just want to start a conversation, then click below.
Learn More

Options for Amortized Expenses - The OBBBA provides important transitional relief, allowing taxpayers to accelerate deductions for domestically incurred R&E expenses during 2022-2024:

  • Option 1: Full Expensing in 2025 - Taxpayers can deduct the remaining unamortized domestic R&E costs in the first tax year post-December 31, 2024.

  • Option 2: Two-Year Amortization - Deduct 50% of the unamortized balance in 2025 and the rest in 2026.

  • Option 3: Continue Amortization - Proceed with the original five-year schedule.

  • Retroactive Expensing for Small Businesses - Eligible small businesses (average annual gross receipts of $31 million or less) can elect retroactive full expensing for tax years after December 31, 2021, via amended returns before July 4, 2026, potentially adjusting R&D tax credits accordingly.

Strategic Integration with Other Tax Provisions - The OBBBA's expensing provisions intertwine significantly with other tax elements like net operating loss, bonus depreciation, business interest limitations, and international taxes. Strategic tax planning is advised to fully comprehend these effects, potentially yielding substantial tax reduction opportunities for businesses. Image 1

Accounting Method Change - The transition rules are treated as an automatic change in accounting method, easing compliance requirements. The ability to "catch-up" on these deductions supplies a crucial cash injection, offering immediate relief from prior capitalization demands. Guidance from the IRS, via Rev Proc 2025-28, outlines the procedural steps, including attaching statements to returns instead of filing Form 3115.

To explore tailored strategies and understand how these provisions affect other tax scenarios like the Net Operating Loss (NOL) rules and business interest expense limitations, contact our office for detailed modeling and advice.

Let’s Start a Conversation.
You can count on us for professional guidance along with timely, and reliable tax services. If you’re ready to get started, or just want to start a conversation, then click below.
Learn More
Share this article...

Want tax & accounting tips and insights?

Sign up for our newsletter.

I confirm this is a service inquiry and not an advertising message or solicitation. By clicking “Submit”, I acknowledge and agree to the creation of an account and to the and .
Let Wastvedt and Company, Inc. remove your tax & accounting stress today.
Contact us to learn more.
Wastvedt and Company, Inc. We love to chat!
Please feel free to use the contact button or use our Ai powered chat assistant.
Please fill out the form and our team will get back to you shortly The form was sent successfully